JW Asset Management
Overview
JW Asset Management is an SEC-registered investment adviser founded in 1998 by Jason Wild. The firm, which began by focusing on undervalued specialty pharmaceutical companies, now invests across both public and private markets with a primary focus on the healthcare and cannabis industries. It employs a long-term growth investment strategy and partners with management teams to provide capital and strategic resources.
Portfolio Companies
3
Website
jwasset.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DaNAgreen Co., Ltd. | Dec 2021 | Series A | Co-investor |
| Allumia | Feb 2022 | Series A Extension | Lead |
| Aprecia Pharmaceuticals | Jan 2016 | Private Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is JW Asset Management based?
JW Asset Management is headquartered in New York City, New York, United States.
When was JW Asset Management founded?
Founding year information for JW Asset Management is not publicly available.
How many portfolio companies does JW Asset Management have?
JW Asset Management has 3 portfolio companies in Caplight's dataset.
What are some companies in JW Asset Management's portfolio?
Portfolio companies visible on Caplight include DaNAgreen Co., Ltd., Allumia, Aprecia Pharmaceuticals.
What was JW Asset Management's most recent investment shown here?
JW Asset Management's most recent investment in this portfolio sample was in Allumia in 2022.
What sectors does JW Asset Management focus on?
JW Asset Management focuses on Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, FinTech.
What company stages does JW Asset Management focus on?
JW Asset Management typically invests at the Early stage.